Stay updated on ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Sign up to get notified when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.

Latest updates to the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed, updating the page's revision tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check17 days agoChange DetectedThe page revision label was updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check25 days agoChange DetectedRemoved the government funding status notice on the page, which previously warned about potential delays in updates and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check39 days agoChange DetectedNo significant updates to core study information are visible between the two screenshots.SummaryDifference0.3%

- Check67 days agoChange DetectedCore content updated with a government-operational notice and a new version tag (v3.2.0); a specific GRDC resource entry was removed (Tenosynovial giant cell tumor, diffuse type) and the version history shows a backward-incompatible removal from v3.1.0 to v3.2.0.SummaryDifference4%

- Check75 days agoChange DetectedUpdate includes a new revision version (v3.1.0) and new contact details; previous revision (v3.0.2) is removed. No evidence of changes to core content beyond the metadata and contact info.SummaryDifference0.1%

Stay in the know with updates to ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.